Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell-Free Nucleic Acids | 5 | 2025 | 59 | 1.950 |
Why?
|
| Plasmodium falciparum | 14 | 2020 | 93 | 1.840 |
Why?
|
| Genetic Privacy | 4 | 2025 | 43 | 1.770 |
Why?
|
| Plasmodium vivax | 6 | 2022 | 27 | 1.400 |
Why?
|
| Malaria, Falciparum | 11 | 2020 | 67 | 1.400 |
Why?
|
| Genetic Carrier Screening | 2 | 2021 | 71 | 1.360 |
Why?
|
| Prenatal Diagnosis | 8 | 2025 | 653 | 1.180 |
Why?
|
| Drug Resistance | 8 | 2019 | 252 | 1.060 |
Why?
|
| Hernia, Umbilical | 2 | 2024 | 45 | 1.050 |
Why?
|
| Malaria, Vivax | 5 | 2022 | 27 | 1.000 |
Why?
|
| Patient Education as Topic | 3 | 2025 | 466 | 0.880 |
Why?
|
| Aneuploidy | 3 | 2025 | 141 | 0.870 |
Why?
|
| alpha-Fetoproteins | 1 | 2024 | 139 | 0.810 |
Why?
|
| Artemisinins | 4 | 2017 | 12 | 0.800 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2024 | 95 | 0.770 |
Why?
|
| Protozoan Proteins | 4 | 2019 | 133 | 0.770 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 1005 | 0.730 |
Why?
|
| Audiovisual Aids | 1 | 2022 | 23 | 0.730 |
Why?
|
| Antimalarials | 7 | 2022 | 47 | 0.690 |
Why?
|
| Awareness | 1 | 2021 | 81 | 0.670 |
Why?
|
| Uncertainty | 1 | 2021 | 96 | 0.660 |
Why?
|
| Laboratories | 1 | 2021 | 84 | 0.660 |
Why?
|
| DNA, Protozoan | 7 | 2018 | 34 | 0.550 |
Why?
|
| Pregnancy | 14 | 2025 | 7575 | 0.550 |
Why?
|
| Malaria Vaccines | 2 | 2015 | 25 | 0.540 |
Why?
|
| Antipruritics | 1 | 2017 | 1 | 0.530 |
Why?
|
| Genetics, Population | 3 | 2016 | 185 | 0.520 |
Why?
|
| Genetic Variation | 5 | 2022 | 1562 | 0.460 |
Why?
|
| Microsatellite Repeats | 3 | 2014 | 232 | 0.440 |
Why?
|
| Cambodia | 5 | 2017 | 15 | 0.430 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2014 | 11 | 0.430 |
Why?
|
| Phylogeography | 1 | 2014 | 14 | 0.420 |
Why?
|
| Pneumocystis carinii | 1 | 2014 | 9 | 0.420 |
Why?
|
| Genes, Fungal | 1 | 2014 | 60 | 0.420 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2014 | 34 | 0.410 |
Why?
|
| Computer Simulation | 1 | 2016 | 684 | 0.400 |
Why?
|
| Genetic Loci | 2 | 2017 | 359 | 0.400 |
Why?
|
| Antigens, Protozoan | 3 | 2018 | 78 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2022 | 934 | 0.350 |
Why?
|
| Computational Biology | 1 | 2016 | 872 | 0.350 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2017 | 153 | 0.340 |
Why?
|
| Anopheles | 3 | 2020 | 28 | 0.310 |
Why?
|
| Phylogeny | 4 | 2017 | 710 | 0.310 |
Why?
|
| Malaria | 3 | 2022 | 101 | 0.300 |
Why?
|
| Haplotypes | 7 | 2020 | 550 | 0.280 |
Why?
|
| Female | 21 | 2025 | 71221 | 0.280 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 185 | 0.260 |
Why?
|
| Humans | 32 | 2025 | 131781 | 0.260 |
Why?
|
| Adult | 16 | 2025 | 31710 | 0.250 |
Why?
|
| Selection, Genetic | 3 | 2016 | 157 | 0.250 |
Why?
|
| Quinolines | 2 | 2017 | 120 | 0.240 |
Why?
|
| Biostatistics | 2 | 2016 | 14 | 0.230 |
Why?
|
| Pulmonary Edema | 1 | 2025 | 57 | 0.230 |
Why?
|
| Hydrops Fetalis | 1 | 2025 | 84 | 0.220 |
Why?
|
| CADASIL | 1 | 2024 | 7 | 0.220 |
Why?
|
| Stillbirth | 1 | 2025 | 103 | 0.210 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17667 | 0.200 |
Why?
|
| Pleural Effusion | 1 | 2024 | 106 | 0.200 |
Why?
|
| Placenta Accreta | 1 | 2025 | 177 | 0.190 |
Why?
|
| Molecular Epidemiology | 4 | 2017 | 146 | 0.180 |
Why?
|
| Software | 2 | 2018 | 752 | 0.180 |
Why?
|
| Parasites | 1 | 2022 | 35 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 321 | 0.170 |
Why?
|
| Genetic Testing | 3 | 2025 | 1101 | 0.170 |
Why?
|
| Privacy | 1 | 2021 | 27 | 0.170 |
Why?
|
| Information Storage and Retrieval | 1 | 2021 | 61 | 0.170 |
Why?
|
| beta-Lactamases | 3 | 2017 | 223 | 0.160 |
Why?
|
| Gestational Age | 1 | 2024 | 1235 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2024 | 5122 | 0.160 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2024 | 464 | 0.160 |
Why?
|
| Chloroquine | 1 | 2019 | 31 | 0.150 |
Why?
|
| Mosquito Vectors | 1 | 2020 | 36 | 0.150 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 155 | 0.150 |
Why?
|
| Treatment Failure | 2 | 2017 | 353 | 0.150 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 208 | 0.150 |
Why?
|
| Exome | 1 | 2024 | 1076 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2021 | 195 | 0.150 |
Why?
|
| Trypanosoma cruzi | 1 | 2022 | 256 | 0.140 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2016 | 74 | 0.140 |
Why?
|
| Piperazines | 2 | 2017 | 272 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2021 | 500 | 0.140 |
Why?
|
| Placenta | 2 | 2025 | 528 | 0.140 |
Why?
|
| Obstetrics | 1 | 2021 | 246 | 0.140 |
Why?
|
| Genotype | 5 | 2017 | 2655 | 0.140 |
Why?
|
| Chagas Disease | 1 | 2022 | 314 | 0.140 |
Why?
|
| Mefloquine | 1 | 2017 | 2 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3616 | 0.130 |
Why?
|
| Dihydropteroate Synthase | 2 | 2014 | 3 | 0.130 |
Why?
|
| Enterobacter cloacae | 1 | 2017 | 13 | 0.130 |
Why?
|
| Genome, Protozoan | 1 | 2016 | 24 | 0.130 |
Why?
|
| Placenta Diseases | 1 | 2017 | 66 | 0.130 |
Why?
|
| Hypertension | 1 | 2025 | 1360 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 170 | 0.130 |
Why?
|
| Endemic Diseases | 1 | 2016 | 61 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 58 | 0.120 |
Why?
|
| Klebsiella Infections | 1 | 2017 | 63 | 0.120 |
Why?
|
| Mutation | 5 | 2024 | 6194 | 0.120 |
Why?
|
| Ecosystem | 1 | 2016 | 98 | 0.120 |
Why?
|
| Disease Outbreaks | 2 | 2017 | 314 | 0.120 |
Why?
|
| Parasitemia | 1 | 2015 | 26 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 1 | 2017 | 89 | 0.120 |
Why?
|
| Species Specificity | 1 | 2016 | 519 | 0.120 |
Why?
|
| Biota | 1 | 2015 | 7 | 0.120 |
Why?
|
| Ixodes | 1 | 2015 | 21 | 0.110 |
Why?
|
| Escherichia coli Infections | 1 | 2017 | 195 | 0.110 |
Why?
|
| Acinetobacter Infections | 1 | 2015 | 36 | 0.110 |
Why?
|
| Insect Vectors | 1 | 2015 | 106 | 0.110 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 47 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 4053 | 0.110 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 311 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 1023 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2872 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2021 | 3696 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8597 | 0.110 |
Why?
|
| Spain | 1 | 2014 | 62 | 0.100 |
Why?
|
| Alphaproteobacteria | 1 | 2013 | 3 | 0.100 |
Why?
|
| Ixodidae | 1 | 2013 | 5 | 0.100 |
Why?
|
| Uganda | 1 | 2014 | 94 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2859 | 0.100 |
Why?
|
| United States | 3 | 2021 | 11815 | 0.100 |
Why?
|
| Sulfadoxine | 1 | 2013 | 2 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3416 | 0.100 |
Why?
|
| North Carolina | 3 | 2017 | 65 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3917 | 0.090 |
Why?
|
| Microbiota | 2 | 2018 | 441 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 500 | 0.090 |
Why?
|
| Hemoglobinopathies | 1 | 2012 | 15 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1398 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2017 | 984 | 0.090 |
Why?
|
| Pregnancy Outcome | 2 | 2025 | 630 | 0.090 |
Why?
|
| Bacteria | 1 | 2015 | 532 | 0.090 |
Why?
|
| Male | 7 | 2024 | 65290 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2018 | 418 | 0.080 |
Why?
|
| HIV Infections | 1 | 2022 | 2037 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 1746 | 0.070 |
Why?
|
| Risk Factors | 2 | 2021 | 10965 | 0.070 |
Why?
|
| Burn Units | 2 | 2017 | 10 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2576 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 12 | 0.060 |
Why?
|
| DNA, Ribosomal | 2 | 2015 | 53 | 0.050 |
Why?
|
| Edema | 1 | 2025 | 139 | 0.050 |
Why?
|
| Lung Volume Measurements | 1 | 2024 | 84 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2015 | 386 | 0.050 |
Why?
|
| DNA, Bacterial | 2 | 2015 | 492 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 1170 | 0.050 |
Why?
|
| Animals | 6 | 2022 | 34402 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2014 | 750 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2025 | 708 | 0.040 |
Why?
|
| Pedigree | 1 | 2024 | 1712 | 0.040 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 944 | 0.040 |
Why?
|
| HIV | 1 | 2022 | 179 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2024 | 461 | 0.040 |
Why?
|
| Coinfection | 1 | 2022 | 192 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2019 | 25 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2299 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2022 | 530 | 0.040 |
Why?
|
| Culicidae | 1 | 2019 | 69 | 0.040 |
Why?
|
| Recurrence | 1 | 2022 | 1483 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2019 | 179 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3451 | 0.030 |
Why?
|
| Benin | 1 | 2017 | 3 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2017 | 31 | 0.030 |
Why?
|
| Young Adult | 3 | 2017 | 10102 | 0.030 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 28 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 85 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2017 | 64 | 0.030 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 44 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 110 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2017 | 52 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2017 | 94 | 0.030 |
Why?
|
| Prevalence | 2 | 2014 | 2695 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 318 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1566 | 0.030 |
Why?
|
| Malawi | 1 | 2017 | 339 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 455 | 0.030 |
Why?
|
| Parasite Load | 1 | 2015 | 31 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 119 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1502 | 0.030 |
Why?
|
| Burns | 1 | 2015 | 92 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 605 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4953 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2014 | 18 | 0.030 |
Why?
|
| Guatemala | 1 | 2014 | 64 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 121 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 853 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1405 | 0.030 |
Why?
|
| Adolescent | 3 | 2017 | 20994 | 0.030 |
Why?
|
| Tanzania | 1 | 2013 | 68 | 0.020 |
Why?
|
| Aged | 3 | 2017 | 21263 | 0.020 |
Why?
|
| Congo | 1 | 2013 | 3 | 0.020 |
Why?
|
| Travel | 1 | 2014 | 129 | 0.020 |
Why?
|
| Geography, Medical | 1 | 2013 | 17 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2013 | 117 | 0.020 |
Why?
|
| alpha-Thalassemia | 1 | 2012 | 11 | 0.020 |
Why?
|
| Hemoglobin, Sickle | 1 | 2012 | 19 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2148 | 0.020 |
Why?
|
| Military Personnel | 1 | 2014 | 210 | 0.020 |
Why?
|
| Middle Aged | 3 | 2017 | 28897 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1347 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 794 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1844 | 0.020 |
Why?
|
| Child | 3 | 2015 | 26316 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 2783 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13324 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2993 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6916 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 15057 | 0.010 |
Why?
|